Home
LIMNW vs INO Comparison

LIMNW vs INO Comparison

Compare LIMNW & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LIMNW

INO

Machine Learning Prediction

ML Decision
LIMNW
INO

Stock Information

Founded
LIMNW N/A
INO 1979

Country
LIMNW United States
INO United States

Employees
LIMNW N/A
INO N/A

Industry
LIMNW
INO Medical/Dental Instruments

Sector
LIMNW
INO Health Care

Exchange
LIMNW Nasdaq
INO Nasdaq

Market Cap
LIMNW N/A
INO N/A

IPO Year
LIMNW N/A
INO 1998

Fundamental

Price
LIMNW $0.30
INO $1.92

Analyst Decision
LIMNW
INO Buy

Analyst Count
LIMNW 0
INO 4

Target Price
LIMNW N/A
INO $9.75

AVG Volume (30 Days)
LIMNW N/A
INO 673.9K

Earning Date
LIMNW N/A
INO 08-07-2025

Dividend Yield
LIMNW N/A
INO N/A

EPS Growth
LIMNW N/A
INO N/A

EPS
LIMNW N/A
INO N/A

Revenue
LIMNW N/A
INO $283,099.00

Revenue This Year
LIMNW N/A
INO $1,691.91

Revenue Next Year
LIMNW N/A
INO $423.63

P/E Ratio
LIMNW N/A
INO N/A

Revenue Growth
LIMNW N/A
INO N/A

52 Week Low
LIMNW N/A
INO $1.42

52 Week High
LIMNW N/A
INO $12.33

Technical

Relative Strength Index (RSI)
LIMNW N/A
INO 44.44

Support Level
LIMNW N/A
INO $2.09

Resistance Level
LIMNW N/A
INO $2.34

Average True Range (ATR)
LIMNW 0.00
INO 0.13

MACD
LIMNW 0.00
INO -0.04

Stochastic Oscillator
LIMNW 0.00
INO 8.89

About LIMNW Liminatus Pharma Inc. Warrants

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.

Share on Social Networks: